116 related articles for article (PubMed ID: 38744219)
1. Galunisertib downregulates mutant type I collagen expression and promotes MSCs osteogenesis in pediatric osteogenesis imperfecta.
Infante A; Alcorta-Sevillano N; Macías I; Cabodevilla L; Medhat D; Lafaver B; Crawford TK; Phillips CL; Bueno AM; Sagastizabal B; Arroyo M; Campino A; Gerovska D; Araúzo-Bravo M; Gener B; Rodríguez CI
Biomed Pharmacother; 2024 Jun; 175():116725. PubMed ID: 38744219
[TBL] [Abstract][Full Text] [Related]
2. Amelioration of osteogenesis in iPSC-derived mesenchymal stem cells from osteogenesis imperfecta patients by endoplasmic reticulum stress inhibitor.
Duangchan T; Tawonsawatruk T; Angsanuntsukh C; Trachoo O; Hongeng S; Kitiyanant N; Supokawej A
Life Sci; 2021 Aug; 278():119628. PubMed ID: 34015290
[TBL] [Abstract][Full Text] [Related]
3. Dysfunction of Caveolae-Mediated Endocytic TβRI Degradation Results in Hypersensitivity of TGF-β/Smad Signaling in Osteogenesis Imperfecta.
Shi C; Sun B; Wu H; Zhang R; Wu L; Guo L; Li C; Xi Y; Yuan W; Zhang Y; Xu G
J Bone Miner Res; 2023 Jan; 38(1):103-118. PubMed ID: 36321807
[TBL] [Abstract][Full Text] [Related]
4. Effect of Anti-TGF-β Treatment in a Mouse Model of Severe Osteogenesis Imperfecta.
Tauer JT; Abdullah S; Rauch F
J Bone Miner Res; 2019 Feb; 34(2):207-214. PubMed ID: 30357929
[TBL] [Abstract][Full Text] [Related]
5. Distinct type I collagen alterations cause intrinsic lung and respiratory defects of variable severity in mouse models of osteogenesis imperfecta.
Dimori M; Fett J; Leikin S; Otsuru S; Thostenson JD; Carroll JL; Morello R
J Physiol; 2023 Jan; 601(2):355-379. PubMed ID: 36285717
[TBL] [Abstract][Full Text] [Related]
6. The synergistic effect of NELL1 and adipose-derived stem cells on promoting bone formation in osteogenesis imperfecta treatment.
Liu Y; Ju M; Wang Z; Li J; Shao C; Fu T; Jing Y; Zhao Y; Lv Z; Li G
Biomed Pharmacother; 2020 Aug; 128():110235. PubMed ID: 32454289
[TBL] [Abstract][Full Text] [Related]
7. Reiterative infusions of MSCs improve pediatric osteogenesis imperfecta eliciting a pro-osteogenic paracrine response: TERCELOI clinical trial.
Infante A; Gener B; Vázquez M; Olivares N; Arrieta A; Grau G; Llano I; Madero L; Bueno AM; Sagastizabal B; Gerovska D; Araúzo-Bravo MJ; Astigarraga I; Rodríguez CI
Clin Transl Med; 2021 Jan; 11(1):e265. PubMed ID: 33463067
[TBL] [Abstract][Full Text] [Related]
8. Modification of COL1A1 in Autologous Adipose Tissue-Derived Progenitor Cells Rescues the Bone Phenotype in a Mouse Model of Osteogenesis Imperfecta.
Liu Y; Wang Z; Ju M; Zhao Y; Jing Y; Li J; Shao C; Fu T; Lv Z; Li G
J Bone Miner Res; 2021 Aug; 36(8):1521-1534. PubMed ID: 33950576
[TBL] [Abstract][Full Text] [Related]
9. Correlations Between Bone Mechanical Properties and Bone Composition Parameters in Mouse Models of Dominant and Recessive Osteogenesis Imperfecta and the Response to Anti-TGF-β Treatment.
Bi X; Grafe I; Ding H; Flores R; Munivez E; Jiang MM; Dawson B; Lee B; Ambrose CG
J Bone Miner Res; 2017 Feb; 32(2):347-359. PubMed ID: 27649409
[TBL] [Abstract][Full Text] [Related]
10. Impact of Genetic and Pharmacologic Inhibition of Myostatin in a Murine Model of Osteogenesis Imperfecta.
Omosule CL; Gremminger VL; Aguillard AM; Jeong Y; Harrelson EN; Miloscio L; Mastaitis J; Rafique A; Kleiner S; Pfeiffer FM; Zhang A; Schulz LC; Phillips CL
J Bone Miner Res; 2021 Apr; 36(4):739-756. PubMed ID: 33249643
[TBL] [Abstract][Full Text] [Related]
11. Circulating TGF-β Pathway in Osteogenesis Imperfecta Pediatric Patients Subjected to MSCs-Based Cell Therapy.
Infante A; Cabodevilla L; Gener B; Rodríguez CI
Front Cell Dev Biol; 2022; 10():830928. PubMed ID: 35223854
[TBL] [Abstract][Full Text] [Related]
12. Irisin reduces bone fracture by facilitating osteogenesis and antagonizing TGF-β/Smad signaling in a growing mouse model of osteogenesis imperfecta.
Sun B; Wu H; Lu J; Zhang R; Shen X; Gu Y; Shi C; Zhang Y; Yuan W
J Orthop Translat; 2023 Jan; 38():175-189. PubMed ID: 36439629
[TBL] [Abstract][Full Text] [Related]
13. Are Changes in Composition in Response to Treatment of a Mouse Model of Osteogenesis Imperfecta Sex-dependent?
Boskey AL; Marino J; Spevak L; Pleshko N; Doty S; Carter EM; Raggio CL
Clin Orthop Relat Res; 2015 Aug; 473(8):2587-98. PubMed ID: 25903941
[TBL] [Abstract][Full Text] [Related]
14. Excessive transforming growth factor-β signaling is a common mechanism in osteogenesis imperfecta.
Grafe I; Yang T; Alexander S; Homan EP; Lietman C; Jiang MM; Bertin T; Munivez E; Chen Y; Dawson B; Ishikawa Y; Weis MA; Sampath TK; Ambrose C; Eyre D; Bächinger HP; Lee B
Nat Med; 2014 Jun; 20(6):670-5. PubMed ID: 24793237
[TBL] [Abstract][Full Text] [Related]
15. Fracture Healing in Collagen-Related Preclinical Models of Osteogenesis Imperfecta.
Zieba J; Munivez E; Castellon A; Jiang MM; Dawson B; Ambrose CG; Lee B
J Bone Miner Res; 2020 Jun; 35(6):1132-1148. PubMed ID: 32053224
[TBL] [Abstract][Full Text] [Related]
16. Mutation analysis of the COL1A1 and COL1A2 genes in Vietnamese patients with osteogenesis imperfecta.
Ho Duy B; Zhytnik L; Maasalu K; Kändla I; Prans E; Reimann E; Märtson A; Kõks S
Hum Genomics; 2016 Aug; 10(1):27. PubMed ID: 27519266
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive genetic analyses using targeted next-generation sequencing and genotype-phenotype correlations in 53 Japanese patients with osteogenesis imperfecta.
Ohata Y; Takeyari S; Nakano Y; Kitaoka T; Nakayama H; Bizaoui V; Yamamoto K; Miyata K; Yamamoto K; Fujiwara M; Kubota T; Michigami T; Yamamoto K; Yamamoto T; Namba N; Ebina K; Yoshikawa H; Ozono K
Osteoporos Int; 2019 Nov; 30(11):2333-2342. PubMed ID: 31363794
[TBL] [Abstract][Full Text] [Related]
18. Osteoblastic differentiation of bone marrow mesenchymal stromal cells in Bruck Syndrome.
Kaneto CM; Lima PS; Zanette DL; Oliveira TY; de Assis Pereira F; Lorenzi JC; Dos Santos JL; Prata KL; Neto JM; de Paula FJ; Silva WA
BMC Med Genet; 2016 May; 17(1):38. PubMed ID: 27146342
[TBL] [Abstract][Full Text] [Related]
19. DNA methyltransferases inhibitor azacitidine improves the skeletal phenotype of mild osteogenesis imperfecta by reversing the impaired osteogenesis and excessive osteoclastogenesis.
Shao C; Liu Y; Zhao Y; Jing Y; Li J; Lv Z; Fu T; Wang Z; Li G
Bone; 2023 May; 170():116706. PubMed ID: 36822490
[TBL] [Abstract][Full Text] [Related]
20. Calvaria Bone Transcriptome in Mouse Models of Osteogenesis Imperfecta.
Moffatt P; Boraschi-Diaz I; Marulanda J; Bardai G; Rauch F
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
